JP2022534973A5 - - Google Patents

Info

Publication number
JP2022534973A5
JP2022534973A5 JP2021570821A JP2021570821A JP2022534973A5 JP 2022534973 A5 JP2022534973 A5 JP 2022534973A5 JP 2021570821 A JP2021570821 A JP 2021570821A JP 2021570821 A JP2021570821 A JP 2021570821A JP 2022534973 A5 JP2022534973 A5 JP 2022534973A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
asd
treatment
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021570821A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534973A (ja
Filing date
Publication date
Priority claimed from HUP1900190A external-priority patent/HU231525B1/hu
Application filed filed Critical
Publication of JP2022534973A publication Critical patent/JP2022534973A/ja
Publication of JP2022534973A5 publication Critical patent/JP2022534973A5/ja
Pending legal-status Critical Current

Links

JP2021570821A 2019-05-31 2020-05-29 自閉症スペクトラム障害を治療するための選択的ヒスタミンｈ３受容体アンタゴニスト Pending JP2022534973A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HUP1900190 2019-05-31
HUP1900190A HU231525B1 (hu) 2019-05-31 2019-05-31 Szelektív hisztamin H3 receptor antagonisták autizmus spektrum betegség kezelésére
PCT/IB2020/055104 WO2020240489A1 (en) 2019-05-31 2020-05-29 Selective histamine h3 receptor antagonists for treating autism spectrum disorder

Publications (2)

Publication Number Publication Date
JP2022534973A JP2022534973A (ja) 2022-08-04
JP2022534973A5 true JP2022534973A5 (https=) 2023-06-06

Family

ID=89992916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021570821A Pending JP2022534973A (ja) 2019-05-31 2020-05-29 自閉症スペクトラム障害を治療するための選択的ヒスタミンｈ３受容体アンタゴニスト

Country Status (8)

Country Link
US (1) US20220235034A1 (https=)
EP (1) EP3976035A1 (https=)
JP (1) JP2022534973A (https=)
CN (1) CN113905736A (https=)
CA (1) CA3141694A1 (https=)
EA (1) EA202193155A1 (https=)
HU (1) HU231525B1 (https=)
WO (1) WO2020240489A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354568T1 (de) * 2000-08-08 2007-03-15 Ortho Mcneil Pharm Inc Nicht-imidazol aryloxypiperidine als h3 rezeptor liganden
HUP1300139A2 (en) * 2013-03-06 2014-09-29 Richter Gedeon Nyrt Phenoxypiperidine h3 antagonists

Similar Documents

Publication Publication Date Title
DE60014163T2 (de) Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung
RU2314810C2 (ru) Способ лечения с использованием лекарственных форм, содержащих фармацевтические композиции 5,8,14-триазатетрацикло[10.3.1.0 (2,11).0(4,9)] гексадека-2( 11),3,5,7,9-пентаена
JP2023503068A5 (https=)
JP2024133474A5 (https=)
JP2023503071A5 (https=)
JP2018193377A5 (https=)
JP2019503365A5 (https=)
JP2016540738A5 (https=)
RU2013121788A (ru) Ингибиторы репликации вич
JP2024075655A5 (ja) 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用
JP2008501760A5 (https=)
JP2014516942A5 (https=)
JP2008501753A5 (https=)
RU2009110452A (ru) Галеновые составы алискирена
JP2023541430A5 (https=)
JP2019516684A5 (https=)
JP2006514092A5 (https=)
JP2007532607A5 (https=)
JP2021529829A5 (https=)
JP2022554276A5 (https=)
JPWO2023054732A5 (https=)
JOP20240269A1 (ar) حلقات كبيرة من إندازول و استخدامها
JP2023553253A5 (https=)
US11253506B2 (en) Compounds, compositions and methods for preventing and/or treating chlorine inhalation toxicity and/or injury
JP2006511538A5 (https=)